Effects of chronic kidney disease and declining renal function on coronary atherosclerotic plaque progression: a PARADIGM substudy

  • Alex L. Huang
    Department of Radiology, St. Paul’s Hospital and University of British Columbia, Vancouver, BC, Canada
  • Jonathon A. Leipsic
    Department of Radiology, St. Paul’s Hospital and University of British Columbia, Vancouver, BC, Canada
  • Sagit Ben Zekry
    Department of Radiology, St. Paul’s Hospital and University of British Columbia, Vancouver, BC, Canada
  • Stephanie Sellers
    Department of Radiology, St. Paul’s Hospital and University of British Columbia, Vancouver, BC, Canada
  • Amir A. Ahmadi
    Centre for Heart Lung Innovation, St. Paul’s Hospital and University of British Columbia, 1081 Burrard St.,Vancouver, BC V6Z 1Y6, Canada
  • Philipp Blanke
    Department of Radiology, St. Paul’s Hospital and University of British Columbia, Vancouver, BC, Canada
  • Martin Hadamitzky
    Department of Radiology and Nuclear Medicine, German Heart Center Munich, Munich, Germany
  • Yong-Jin Kim
    Department of Cardiology, Seoul National University Hospital, Seoul, South Korea
  • Edoardo Conte
    Department of Radiology and Cardiology, Centro Cardiologico Monzino, IRCCS, Milan, Italy
  • Daniele Andreini
    Department of Radiology and Cardiology, Centro Cardiologico Monzino, IRCCS, Milan, Italy
  • Gianluca Pontone
    Department of Radiology and Cardiology, Centro Cardiologico Monzino, IRCCS, Milan, Italy
  • Matthew J. Budoff
    Department of Medicine, Harbor UCLA Medical Center, Los Angeles, CA, USA
  • Ilan Gottlieb
    Department of Radiology, Casa de Saude São Jose, Rio de Janeiro, Brazil
  • Byoung Kwon Lee
    Department of Cardiology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, South Korea
  • Eun Ju Chun
    Department of Cardiology, Seoul National University Bundang Hospital, Bundang, South Korea
  • Filippo Cademartiri
    Department of Radiology, Montreal Heart Institute, Montreal, Quebec, Canada
  • Erica Maffei
    Department of Radiology, Erasmus University Medical Center, Rotterdam, The Netherlands
  • Hugo Marques
    Department of Cardiology, Hospital da Luz, Lisbon, Portugal
  • Sanghoon Shin
    Department of Cardiology, National Health Insurance Service Ilsan Hospital, South Korea
  • Jung Hyun Choi
    Department of Cardiology, Busan University Hospital, Busan, South Korea
  • Renu Virmani
    Department of Pathology, CVPath Institute, Gaithersburg, MD, USA
  • Habib Samady
    Division of Cardiology, Emory University School of Medicine, Atlanta, GA, USA
  • Peter H. Stone
    Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
  • Daniel S. Berman
    Department of Imaging, Cedars-Sinai Medical Center, Cedars-Sinai Heart Institute, Los Angeles, CA, USA
  • Jagat Narula
    Department of Cardiology, Icahn School of Medicine at Mt. Sinai Hospital, New York, NY, USA
  • Leslee J. Shaw
    Department of Radiology, Weill Cornell Medical College, New York, NY, USA
  • Jeroen J. Bax
    Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, The Netherlands
  • Hyuk-Jae Chang
    Division of Cardiology, Severance Cardiovascular Hospital, Integrative Cardiovascular Imaging Center, Yonsei University College of Medicine, Seoul, South Korea

抄録

<jats:title>Abstract</jats:title> <jats:sec> <jats:title>Aims </jats:title> <jats:p>To investigate the change in atherosclerotic plaque volume in patients with chronic kidney disease (CKD) and declining renal function, using coronary computed tomography angiography (CCTA).</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and results</jats:title> <jats:p>In total, 891 participants with analysable serial CCTA and available glomerular filtration rate (GFR, derived using Cockcroft–Gault formulae) at baseline (CCTA 1) and follow-up (CCTA 2) were included. CKD was defined as GFR &lt;60 mL/min/1.73 m2. Declining renal function was defined as ≥10% drop in GFR from the baseline. Quantitative assessment of plaque volume and composition were performed on both scans. There were 203 participants with CKD and 688 without CKD. CKD was associated with higher baseline total plaque volume, but similar plaque progression, measured by crude (57.5 ± 3.4 vs. 65.9 ± 7.7 mm3/year, P = 0.28) or annualized (17.3 ± 1.0 vs. 19.9 ± 2.0 mm3/year, P = 0.25) change in total plaque volume. There were 709 participants with stable GFR and 182 with declining GFR. Declining renal function was independently associated with plaque progression, with higher crude (54.1 ± 3.2 vs. 80.2 ± 9.0 mm3/year, P &lt; 0.01) or annualized (16.4 ± 0.9 vs. 23.9 ± 2.6 mm3/year, P &lt; 0.01) increase in total plaque volume. In CKD, plaque progression was driven by calcified plaques whereas in patients with declining renal function, it was driven by non-calcified plaques.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Decline in renal function was associated with more rapid plaque progression, whereas the presence of CKD was not.</jats:p> </jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ